Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 3 studies | 17% ± 1% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 100% | 4432.34 | 245 / 245 | 100% | 11.77 | 502 / 502 |
brain | 99% | 1694.36 | 2617 / 2642 | 99% | 12.54 | 701 / 705 |
thymus | 100% | 9438.93 | 653 / 653 | 98% | 11.98 | 595 / 605 |
esophagus | 100% | 1684.10 | 1438 / 1445 | 98% | 7.04 | 180 / 183 |
adrenal gland | 100% | 3383.25 | 257 / 258 | 97% | 6.64 | 224 / 230 |
pancreas | 99% | 1518.88 | 325 / 328 | 96% | 6.83 | 171 / 178 |
ovary | 100% | 3762.31 | 180 / 180 | 94% | 7.97 | 406 / 430 |
uterus | 100% | 3606.35 | 170 / 170 | 93% | 6.36 | 426 / 459 |
breast | 100% | 3447.76 | 459 / 459 | 92% | 5.82 | 1028 / 1118 |
intestine | 100% | 1864.83 | 964 / 966 | 92% | 4.90 | 484 / 527 |
stomach | 100% | 1673.01 | 359 / 359 | 91% | 4.93 | 261 / 286 |
bladder | 100% | 2245.86 | 21 / 21 | 89% | 6.02 | 450 / 504 |
lung | 98% | 1822.21 | 569 / 578 | 88% | 6.57 | 1020 / 1155 |
skin | 92% | 1956.67 | 1659 / 1809 | 94% | 7.82 | 445 / 472 |
kidney | 99% | 3713.71 | 88 / 89 | 83% | 6.40 | 745 / 901 |
liver | 91% | 1111.64 | 205 / 226 | 85% | 5.30 | 345 / 406 |
lymph node | 0% | 0 | 0 / 0 | 100% | 7.11 | 29 / 29 |
spleen | 100% | 2929.76 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 16.54 | 1 / 1 |
adipose | 100% | 3203.77 | 1202 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 99% | 1426.23 | 1315 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 96% | 9.20 | 77 / 80 |
peripheral blood | 95% | 1434.00 | 882 / 929 | 0% | 0 | 0 / 0 |
heart | 87% | 862.37 | 750 / 861 | 0% | 0 | 0 / 0 |
muscle | 85% | 704.35 | 682 / 803 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 84% | 5.40 | 38 / 45 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0019731 | Biological process | antibacterial humoral response |
GO_0006935 | Biological process | chemotaxis |
GO_0035774 | Biological process | positive regulation of insulin secretion involved in cellular response to glucose stimulus |
GO_2000304 | Biological process | positive regulation of ceramide biosynthetic process |
GO_0034638 | Biological process | phosphatidylcholine catabolic process |
GO_0046338 | Biological process | phosphatidylethanolamine catabolic process |
GO_0035965 | Biological process | cardiolipin acyl-chain remodeling |
GO_0046473 | Biological process | phosphatidic acid metabolic process |
GO_0046469 | Biological process | platelet activating factor metabolic process |
GO_0032049 | Biological process | cardiolipin biosynthetic process |
GO_0038096 | Biological process | Fc-gamma receptor signaling pathway involved in phagocytosis |
GO_0005615 | Cellular component | extracellular space |
GO_0005886 | Cellular component | plasma membrane |
GO_0005739 | Cellular component | mitochondrion |
GO_0016607 | Cellular component | nuclear speck |
GO_0005829 | Cellular component | cytosol |
GO_0015630 | Cellular component | microtubule cytoskeleton |
GO_0031143 | Cellular component | pseudopodium |
GO_0052816 | Molecular function | long-chain fatty acyl-CoA hydrolase activity |
GO_0004623 | Molecular function | phospholipase A2 activity |
GO_0047499 | Molecular function | calcium-independent phospholipase A2 activity |
GO_0017171 | Molecular function | serine hydrolase activity |
GO_0016787 | Molecular function | hydrolase activity |
GO_0042802 | Molecular function | identical protein binding |
GO_0004622 | Molecular function | lysophospholipase activity |
GO_0102545 | Molecular function | phosphatidyl phospholipase B activity |
GO_0003847 | Molecular function | 1-alkyl-2-acetylglycerophosphocholine esterase activity |
GO_0005516 | Molecular function | calmodulin binding |
GO_0005515 | Molecular function | protein binding |
Gene name | PLA2G6 |
Protein name | Phospholipase A2 group VI 85/88 kDa calcium-independent phospholipase A2 (CaI-PLA2) (EC 3.1.1.4) (2-lysophosphatidylcholine acylhydrolase) (EC 3.1.1.5) (Group VI phospholipase A2) (GVI PLA2) (Intracellular membrane-associated calcium-independent phospholipase A2 beta) (iPLA2-beta) (Palmitoyl-CoA hydrolase) (EC 3.1.2.2) (Patatin-like phospholipase domain-containing protein 9) (PNPLA9) phospholipase A2 (EC 3.1.1.4) |
Synonyms | PLPLA9 |
Description | FUNCTION: Calcium-independent phospholipase involved in phospholipid remodeling with implications in cellular membrane homeostasis, mitochondrial integrity and signal transduction. Hydrolyzes the ester bond of the fatty acyl group attached at sn-1 or sn-2 position of phospholipids (phospholipase A1 and A2 activity respectively), producing lysophospholipids that are used in deacylation-reacylation cycles . Hydrolyzes both saturated and unsaturated long fatty acyl chains in various glycerophospholipid classes such as phosphatidylcholines, phosphatidylethanolamines and phosphatidates, with a preference for hydrolysis at sn-2 position . Can further hydrolyze lysophospholipids carrying saturated fatty acyl chains (lysophospholipase activity) . Upon oxidative stress, contributes to remodeling of mitochondrial phospholipids in pancreatic beta cells, in a repair mechanism to reduce oxidized lipid content . Preferentially hydrolyzes oxidized polyunsaturated fatty acyl chains from cardiolipins, yielding monolysocardiolipins that can be reacylated with unoxidized fatty acyls to regenerate native cardiolipin species (By similarity). Hydrolyzes oxidized glycerophosphoethanolamines present in pancreatic islets, releasing oxidized polyunsaturated fatty acids such as hydroxyeicosatetraenoates (HETEs) (By similarity). Has thioesterase activity toward fatty-acyl CoA releasing CoA-SH known to facilitate fatty acid transport and beta-oxidation in mitochondria particularly in skeletal muscle . Plays a role in regulation of membrane dynamics and homeostasis. Selectively hydrolyzes sn-2 arachidonoyl group in plasmalogen phospholipids, structural components of lipid rafts and myelin (By similarity). Regulates F-actin polymerization at the pseudopods, which is required for both speed and directionality of MCP1/CCL2-induced monocyte chemotaxis . Targets membrane phospholipids to produce potent lipid signaling messengers. Generates lysophosphatidate (LPA, 1-acyl-glycerol-3-phosphate), which acts via G-protein receptors in various cell types (By similarity). Has phospholipase A2 activity toward platelet-activating factor (PAF, 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine), likely playing a role in inactivation of this potent pro-inflammatory signaling lipid (By similarity). In response to glucose, amplifies calcium influx in pancreatic beta cells to promote INS secretion (By similarity). .; FUNCTION: [Isoform Ankyrin-iPLA2-1]: Lacks the catalytic domain and may act as a negative regulator of the catalytically active isoforms. .; FUNCTION: [Isoform Ankyrin-iPLA2-2]: Lacks the catalytic domain and may act as a negative regulator of the catalytically active isoforms. . |
Accessions | ENST00000427114.6 ENST00000663895.1 [O60733-1] A0A590UK67 ENST00000594306.1 ENST00000673413.1 A0A590UK51 ENST00000454670.1 O60733 ENST00000668949.1 A0A590UJZ2 M0R3D9 ENST00000668499.1 A0A3Q9WQR3 ENST00000667521.1 [O60733-1] B0QYE9 A0A590UJH4 ENST00000448094.5 ENST00000452542.5 ENST00000332509.8 [O60733-1] ENST00000436218.6 H0Y6T3 H7C3P5 ENST00000664587.1 A0A3T0ZC00 M0R1Q9 ENST00000498338.1 ENST00000660610.1 [O60733-1] ENST00000430886.5 H0Y7G5 F8WEQ9 ENST00000665987.1 ENST00000655142.1 ENST00000335539.7 [O60733-2] F8WEN3 ENST00000402064.5 [O60733-2] E7EX67 A0A3S5IBI3 ENST00000455341.2 A0A590UJC7 A0A3T0ZC14 |